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Renal failure predisposes patients to adverse outcome after as advanced age, diabetes mellitus, hypertension, conges-
coronary artery bypass surgery. tive heart failure, and diffuse vascular disease, that are
Background. More than 600,000 coronary artery bypass graft often associated with impaired renal function [1–12]. For(CABG) procedures are done annually in the United States.
example, one recent multicenter study of more than 2000Some data indicate that 10 to 20% of patients who are undergo-
CABG patients found that 14% of these patients had ating a CABG procedure have a serum creatinine of more than
1.5 mg/dl. There are few data on the impact of a mild increase least some degree of impaired renal function prior to
in serum creatinine concentration on CABG outcome. surgery [11].
Methods. We analyzed a Veterans Affairs database obtained The presence of impaired renal function potentiallyprospectively from 1992 through 1996 at 14 of 43 centers per-
results in several physiologic abnormalities that couldforming heart surgery. We compared the outcome after CABG
contribute to adverse operative outcome. Indeed, thein patients with a baseline serum creatinine of less than 1.5
mg/dl (median 1.1 mg/dl, N 5 3271) to patients with a baseline absence of renal function has been well documented to
serum creatinine of 1.5 to 3.0 mg/dl (median 1.7, N 5 631). be associated with relatively high morbidity and mortal-
Results. Univariate analysis revealed that patients with a
ity after surgery, including cardiac surgery, despite renalserum creatinine of 1.5 to 3.0 mg/dl had a higher 30-day mortal-
replacement therapy [13–15]. There is, however, limitedity (7% vs. 3%, P , 0.001) requirement for prolonged mechani-
cal ventilation (15% vs. 8%, P 5 0.001), stroke (7% vs. 2%, information on the effects of lesser degrees of renal fail-
P , 0.001), renal failure requiring dialysis at discharge (3% ure on CABG outcome [1, 4, 5, 11, 12].
vs. 1%, P , 0.001), and bleeding complications (8% vs. 3%, This study was therefore undertaken to test the hy-
P , 0.001) than patients with a baseline serum creatinine of
pothesis that mild-to-moderate renal failure (defined asless than 1.5 mg/dl. Multiple logistic regression analyses found
a serum creatinine concentration of 1.5 to 3.0 mg/dl) isthat patients with a baseline serum creatinine of less than 1.5
mg/dl had significantly lower (P , 0.02) 30-day mortality and an independent risk factor for adverse outcome after
postoperative bleeding and ventilatory complications than pa- CABG. To test this hypothesis, we used a large Veterans
tients with a serum creatinine of 1.5 to 3.0 mg/dl when control- Affairs (VA) database. This database contained exten-
ling for all other variables.
sive data on comorbid conditions, preoperative status,Conclusion. These results demonstrate that mild renal failure
and post-CABG complications collected on more thanis an independent risk factor for adverse outcome after CABG.
3900 patients. Our multivariate analysis results demon-
strate that mild-to-moderate renal failure is an indepen-
dent risk factor for adverse outcome after CABG whenMore than 600,000 patients undergo coronary artery
all other risk factors are held constant. Our results alsobypass grafting (CABG) annually in the United States.
delineate some of the specific post-CABG complicationsMany of these patients have comorbid conditions, such
associated with mild-to-moderate renal failure.
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from September 8, 1992, through December 31, 1996, lytic therapy within 48 hours prior to surgery, and any
complication from preoperative heart catheterization.from 14 of 43 VA hospitals with cardiac surgery pro-
grams. The VA hospitals were chosen to represent a Logistical regression models were analyzed using a
forward, stepwise selection method with model entry crite-spectrum of hospitals across the distribution of risk-
adjusted 30-day mortality from CABG. A total of 4969 ria set at a P , 0.25, allowing SAS to select the best fit
model, and P , 0.05 as the model exit criteria, respec-patients was entered, of which 3956 underwent a CABG
procedure without an additional cardiac surgical proce- tively. The models were evaluated by both the predictive
power of the model using the concordance or C-indexdure. Data obtained from 3954 of these CABG patients
who had at least one baseline serum creatinine determi- and the Hosmer-Lemeshow goodness-of-fit test statistic
[19, 20]. Five different outcome variables (30-day opera-nation done within two weeks of CABG form the basis
of this report. tive death, and four groups of postoperative complica-
tions) were examined with multivariable logistic regres-Prior to data analysis, we categorized patients by three
levels of baseline serum creatinine concentration. We sion analysis. The groups of postoperative complications
that were studied included bleeding (defined as dissemin-divided patients into clinically relevant categories of a
serum creatinine of less than 1.5 mg/dl (a normal value ated intravascular coagulopathy, gastrointestinal bleed-
ing, or return to the operating room for cardiothoracicfor most hospital laboratories), 1.5 to 3.0 mg/dl (a value
considered by many to be mild-to-moderate renal failure bleeding), infections (defined as pneumonia, harvest site
wound, chest wound, mediastinitis, or endocarditis infec-that is usually asymptomatic and felt to have only minor
clinical relevance), and more than 3.0 mg/dl (considered tions), cardiac complications (defined as cardiac arrest
or congestive heart failure symptoms), and respiratoryto be indicative of more advanced renal insufficiency)
[16]. No data on creatinine clearance were obtained, and complications (defined as mechanical ventilation support
for longer than 48 hr or the need for reintubation). Thesea more detailed analysis (such as use of the Cockcroft-
Gault nomogram) of renal function was not available clinical variables were examined because renal failure
from the database. results in physiologic abnormalities that could potentially
Extensive preoperative and postoperative data were predispose patients to several of these events [16].
obtained on each patient as described in detail in a previ- As cost data were not available, length of stay variables
ous publication [17]. Statistical comparisons of these were developed and analyzed as surrogates for cost. Post-
variables in the three groups of patients categorized by operative length of stay was defined as the time from
serum creatinine concentration were done by chi-square surgery to discharge. Total length of stay was defined as
tests, Fisher’s exact test and Mantel-Haenszel test where the time from admission to discharge. In the Department
appropriate for categorical variables, and by Kruskal- of Veterans Affairs health care system, medical care days
Wallis tests for continuous variables. Length of stay vari- are not tracked separately from nonmedical care days
ables were analyzed using Kaplan-Meier analysis censor- (for example, days within the hospital that a patient
ing for deaths prior to discharge. The Wilcoxon rank awaited discharge for transportation reasons). Thus, the
sum and log rank test statistics were used to compare length of stay data may be biased, as over 50% of patients
strata. To ascertain if renal failure was independently traveled in excess of 50 miles for the CABG procedure.
associated with adverse outcomes that were dichotomous A Cox proportional hazards model, accounting for pa-
in nature, multivariate analyses were done using a logistic tient risk factors other than renal function, was used to
regression risk model. Initially, a model for estimating differentiate whether the impact of renal function was
risk of death in each CABG patient, developed from the an independent predictor of length of stay.
Continuous Improvement in Cardiac Surgery Study, was
used [1, 4, 18]. The significant variables in predicting 30-
RESULTSday operative death in this model were previous myocar-
The mean age of this study’s CABG-only patient pop-dial infarction, priority of surgery (elective, urgent, or
ulation was 63.5 years, and 99% were male. Ten percentemergent), the New York Heart Association Classifica-
of patients had prior heart surgery. Of the 3954 studytion, the Canadian Cardiovascular Society Angina Clas-
population, 82.7% had a baseline serum creatinine ofsification, age, history of chronic obstructive pulmonary
less than 1.5 mg/dl, 16% between 1.5 and 3.0 mg/dl, anddisease, cardiomegaly, prior heart surgery, history of pe-
1.3% more than 3.0 mg/dl. Median total (preoperativeripheral vascular disease, history of cerebrovascular dis-
and postoperative) length of stay for the entire groupease, current diuretic use, the American Society of Anes-
was 13.5 days. Thirty-day operative mortality for thethesiologist Classification, and preoperative intra-aortic
study population was 3.7%.balloon use [1, 4, 18]. Additional variables used in the
The characteristics of patients categorized by baselinemodel building process in this study included the pres-
serum creatinine concentrations are depicted in Table 1.ence of diabetes mellitus, current bronchodilator use,
current smoking history, hypertension history, thrombo- The median serum creatinine concentration in the three
Anderson et al: Renal failure and coronary artery bypass 1059
Table 1. Characteristics of study subjects withoug and with baseline serum creatinine concentrations less than and greater than 1.5 mg/dl
Serum creatinine
,1.5 mg/dl 1.5–3.0 mg/dl .3.0 mg/dl
Variable (N 5 3,271) (N 5 631) (N 5 52) P
Median serum creatinine mg/dl 1.1 1.7 4.6 ,0.001
Age years 62.6 67.9 62.8 ,0.001
Preoperative intra-aortic balloon pump N (%) 140 (4) 31 (5) 1 (2) 0.608
History of prior myocardial infarction N (%) 1,926 (59) 403 (64) 32 (62) 0.063
Non-elective surgery N (%) 719 (22) 123 (19) 17 (33) 0.168
New York Heart Association Classification III and IV N (%) 1,065 (33) 256 (40) 28 (54) 0.001
Angina function classification III or IV N (%) 2,299 (70) 433 (68) 38 (73) 0.135
History of peripheral vascular disease N (%) 845 (26) 219 (35) 15 (29) 0.001
History of cerebral vascular disease N (%) 530 (16) 184 (29) 15 (29) 0.001
History of hypertension N (%) 1,895 (58) 449 (71) 49 (94) 0.001
History of chronic obstructive long disease N (%) 504 (13) 102 (16) 13 (25) 0.156
Presence of diabetes mellitus N (%) 820 (25) 203 (32) 23 (44) 0.001
Current smoker N (%) 924 (28) 124 (20) 9 (17) 0.001
Bronchodilator use N (%) 368 (11) 111 (18) 15 (29) 0.001
Diuretic use N (%) 630 (19) 282 (45) 30 (58) 0.001
Prior heart surgery N (%) 305 (9) 67 (11) 7 (13) 0.380
Table 2. Post-operative complication rates in three groups of longed ventilation and reintubation), neurologic (coma
patients classified by baseline serum creatinine
for more than 24 hr and stroke), gastrointestinal (bleed-of ,1.5, 1.5–3.0 and .3.0 mg/dl
ing), and renal (renal failure requiring dialysis after dis-
Serum creatinine charge) complications. Three infectious complications
,1.5 1.5–3.0 .3.0 (mediastinitis, graft harvest site, and chest wound) did
Complication % mg/dl mg/dl mg/dl P
not have a significant difference between the three groups
30-day mortality 3.0 6.8 7.7 ,0.001 of patients, whereas the occurrence of pneumonia andMyocardial infarction 4.2 4.0 3.8 0.953
endocarditis was significantly different. The occurrenceCardiac arrest 2.7 4.3 3.8 0.063
Congestive heart failure symptoms 1.4 3.5 1.9 0.002 of congestive heart failure symptoms and of endocarditis
On ventilator .48 hours 7.6 14.9 19.2 0.001 did not progressively increase in concert with the degreeReintubated 3.7 6.7 11.5 ,0.001
Coma .24 hours 0.6 1.4 3.8 0.01 of renal failure.
Stroke 2.1 6.5 7.7 ,0.001 Using multivariable logistic regression analysis, mild-
Gastrointestinal bleeding 0.6 2.7 3.8 ,0.001
to-moderate chronic renal failure (serum creatinine ofPneumonia 4.8 6.2 13.5 0.012
Harvest site infection 2.0 2.5 3.8 0.268 1.5 to 3.0 mg/dl) significantly increased 30-day operative
Chest wound infection 2.0 3.0 1.9 0.244 mortality (P 5 0.017), bleeding complications (defined as
Mediastinitis 1.0 1.7 1.9 0.211
disseminated intravascular coagulation, gastrointestinalEndocarditis 0.1 0 1.9 0.043
Renal failure requiring dialysis at hemorrhage, or thoracic hemorrhage sufficient to require
discharge 0.9 3.3 13.5 0.001 reoperation, P , 0.001), cardiac complications (defined
as cardiac arrest and low cardiac output, P 5 0.049), and
ventilatory complications (defined as greater than 48 hr
of mechanical ventilation and/or reintubation, P , 0.001)study groups was 1.1, 1.7, and 4.6 mg/dl, respectively. In
independent of other variables relative to patients withgeneral, patients with a serum creatinine of 1.5 mg/dl or
a serum creatinine concentration of less than 1.5 mg/dl.higher tended to be smokers less often and to more often
Multivariable comparisons were made using the lesshave had a history of diabetes mellitus, peripheral and/or
than 1.5 mg/dl baseline serum creatinine group as thecerebrovascular disease, hypertension, current bronchodi-
reference for comparison. The odds ratio with 95% con-lator use, current diuretic use, and more often they had
fidence intervals when comparing patients with a serumNew York Heart Association Class III or IV heart failure.
creatinine of 1.5 to 3.0 mg/dl with the reference groupAs noted in the Methods section, all of these variables
was 1.63 (1.09 to 2.44) for 30-day mortality, 2.29 (1.59were eligible for entry in our model-building process.
to 3.29) for bleeding, 1.66 (1.27 to 2.15) for ventilatorySeveral post-CABG outcomes in the three groups of
complications, and 1.46 (1.00 to 2.12) for cardiac compli-patients, categorized by baseline serum creatinine con-
cations. All of the Hosmer-Lemeshow goodness-of-fitcentration, are depicted in Table 2. Univariately, the
test statistics were acceptable (P . 0.05) for the finalserum creatinine grouping was significantly associated
study models for 30-day mortality, bleeding, infections,with increased 30-day operative mortality as well as con-
gestive heart failure symptoms, selected pulmonary (pro- and cardiac complications. However, the Hosmer-Lem-
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Table 3. Transfusions in patients with serum creatinine DISCUSSION
,1.5, 1.5–3.0 and 3.0 mg/dl
Preoperative assessment, which usually focuses on the
Serum creatinine cardiovascular system, allows a determination if modifi-
,1.5 1.5–3.0 .3.0 able risk factors for adverse operative outcome are pres-
mg/dl mg/dl mg/dl P
ent [21–23]. Such risk stratification not only permits indi-
Average number of units of blood vidualized management tailored to patient needs, buttransfused intra- and
also allows better informed consent. Moreover, identifi-post-operatively 1.90 3.45 4.12 ,0.001
Average number of units of fresh cation of risk factors can result in the development of
frozen plasma given intra- risk adjustment models that may be credible indicatorsand post-operatively 0.80 1.34 1.45 ,0.001
of perioperative quality of care [1, 2, 24].Average number of units of
platelets transfused intra- Although it is well established that severe chronic re-
and post-operatively 2.15 3.35 5.00 ,0.001 nal failure predisposes patients to adverse operative out-
In this analysis, the P value was calculated by the Kruskal-Wallis Test. come [13–15, 25] and increased resource utilization [26],
there is modest information on the effects of lesser de-
grees of renal failure on operative outcome. Browner
and Mangano initially suggested impaired renal functioneshow test indicated an inadequate fit for the final respi-
as an important predictor of postoperative mortality [3].ratory model (P 5 0.0266). Multivariable analysis with
In this study of 474 male veterans with either knownregard to selected infectious complications (pneumonia,
coronary artery disease or with a high risk for coronary
harvest site, chest wound, mediastinitis, and endocardi-
artery disease, a reduced estimated creatinine clearance
tis) demonstrated no significant effect of patients with a
was a powerful (odds ratio 6.8; 95% confidence intervals,
serum creatinine less than and greater than 1.5 mg/dl
2.8 to 16), independent predictor of postoperative mor-
when added to the original model.
tality following noncardiac surgery [3]. With regard to
Multivariable logistic regression analysis comparing
cardiac valvular surgery that sometimes included a CABG
patients with a baseline serum creatinine of more than procedure, Grover, Hammermeister and Burchfiel stud-
3.0 mg/dl to the group with a serum creatinine of 1.5 to ied a large VA database [1] and found that the mean
3.0 mg/dl did not reveal significant differences in 30-day serum creatinine concentration was significantly lower
operative mortality (P 5 0.75), bleeding complications (1.3 mg/dl) in survivors than in nonsurvivors (1.7 mg/dl,
(P 5 0.49), cardiac complications (P 5 0.36), or ventila- P , 0.001). O’Connor et al, after an analysis of more
tory complications (P 5 0.55). than 3000 patients from five centers, found that “preex-
With regard to the risk of bleeding complications and isting renal failure” (magnitude not otherwise defined)
renal function, the data depicted in Table 3 indicate a significantly increased in-hospital mortality following
significant, stepwise increase in the average number of CABG (odds ratio 5.2, 95% confidence intervals, 2.5 to
units of transfused red blood cells, fresh frozen plasma, 11.1) [5]. More recently, Mangano et al analyzed out-
and platelets in the intraoperative and postoperative pe- comes in more than 2200 patients from 24 university
riods in the groups of patients with increasing serum hospitals having CABG with or without valvular surgery
creatinine concentration. The percentage of patients with and reported that the presence of mild renal failure (pre-
a baseline serum creatinine concentration of less than operative serum creatinine of 1.4 to 2.0 mg/dl) was an
1.5, 1.5 to 3.0, and more than 3.0 mg/dl that received red independent, significant predictor of the development of
blood cells (55, 75, and 83%, respectively), fresh frozen post-CABG acute renal failure [11]. Post-CABG acute
plasma (21, 28, and 31%, respectively), and platelet renal failure, in turn, was associated with increased mor-
transfusions (21, 29, and 46%, respectively) increased in bidity and mortality [11]. Finally, Shroyer, Grover and
parallel with the magnitude of increase in serum creati- Edwards analyzed more than 135,000 CABG patient
nine level. records from The Society of Thoracic Surgeons National
With regard to length of stay, stratified Kaplan-Meier Adult Cardiac Data Base and found that a preoperative
analysis demonstrated univariately that the group with a serum creatinine concentration of 2.0 mg/dl or above
baseline serum creatinine of 1.5 to 3.0 mg/dl also had was significantly associated with increased postoperative
a significantly longer length of stay than the group with death, with an odds ratio of 2.01 [12].
a baseline serum creatinine of less than 1.5 mg/dl (16 vs. Data from our analyses confirm and significantly ex-
13 days, respectively, P , 0.001). Also, patients with a tend many of these observations. We found that several
baseline serum creatinine of more than 3.0 mg/dl had a adverse outcomes occurred with significantly greater fre-
significantly longer median total length of stay than those quency when patients with mild-to-moderate increases
with a serum creatinine of 1.5 to 3.0 mg/dl (20 vs. 16 in serum creatinine (1.5 to 3.0 mg/dl) were compared
with patients with a normal baseline serum creatininedays, respectively, P , 0.001).
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concentration of less than 1.5 mg/dl. Multivariable logis- mild-to-moderate renal failure and adverse ventilation
outcomes are required.tic regression analysis demonstrated that mild-to-moder-
In view of our findings that mild-to-moderate renalate chronic renal failure was associated with significantly
failure appears to be significantly associated with en-increased 30-day operative mortality, as well as selected
hanced bleeding and respiratory complications, a recentbleeding and respiratory complications independent of
case-control study is of interest [30]. This study foundother variables. Cox proportional hazard analysis dem-
that, after adjusting for differences in comorbidity, mildonstrated that the presence of an elevated baseline serum
radiocontrast-induced acute renal dysfunction was asso-creatinine concentration was also associated with sig-
ciated with a remarkably high mortality (odds ratio ofnificantly increased length of stay. Taken together, these
dying of 5.5) and that the clinical course was often com-and previous studies clearly demonstrate that mild-to-
plicated by the occurrence of bleeding and respiratorymoderate renal failure is a significant, independent risk
complications in nonoperative patients [30].factor associated with post-CABG mortality and mor-
We should note some limitations to our analysis. First,bidity as well as resource consumption. This study also
our study was observational in nature, and it is possibledelineates selected, specific complications associated
that we were unable to identify and analyze all potentialwith mild-to-moderate renal failure.
confounding factors. We consider, however, the observa-The association of perioperative bleeding with mild
tional nature of our study a strength rather than a limita-renal failure is one of the most interesting observations
tion. Thus, our results are much more representative ofof this study. We found that mild renal failure was associ-
the population of VA patients undergoing CABG thanated with not only an increased frequency of clinical
populations reported with other study designs such asbleeding, but also with the need for more blood, fresh
randomized trials, which tend to include highly selectedfrozen plasma, and platelet transfusions. Most studies
patients. Moreover, no other study has collected as com-emphasize that renal failure-associated bleeding usually
prehensive a set of risk factors and outcomes in CABGoccurs in the setting of advanced degrees of renal failure
patients. Second, our population was drawn from a VA[27, 28]. The median and mean serum creatinine concen-
patient population and was comprised nearly exclusivelytrations present in our mild-to-moderate renal failure
of males. Thus, our results may not be generalizable.group were 1.70 and 1.77 mg/dl, respectively, which are
Third, our subgroup of patients with a baseline serummuch lower than those reported in patients with renal
creatinine of more than 3.0 mg/dl was small, and we werefailure-associated bleeding. It is possible that mild-to-
unable to demonstrate a “dose–response” relationshipmoderate renal failure interacts with other factors associ-
between the severity of renal failure and some adverseated with either coronary artery disease (such as anti-
post-CABG outcomes. The relatively small sample size
platelet therapy) or the CABG procedure (such as car-
(0.13% of our entire patient sample) of our patients with
diopulmonary bypass) [29] to promote perioperative a baseline serum creatinine concentration of more than
bleeding synergistically. Additional studies are needed 3.0 mg/dl thus limits conclusions that can be drawn re-
to determine the causes of the association of mild-to- garding this subset of patients. A power analysis indicates
moderate renal failure and the clinically important com- that our current ability to detect a difference between
plication of perioperative bleeding. the high and moderate patient subgroup is approximately
Also, our results demonstrating a significant relation- 22%. Fourth, our means of categorizing the presence
ship between mild-to-moderate renal failure and ventila- and degree of renal failure was discretionary. Indeed, it
tory complications are of interest. Our analysis does not is likely that small, older patients with a serum creatinine
allow us to determine the cause of the prolonged me- concentration of 1.3 to 1.4 mg/dl had significant renal
chanical ventilation and the need for reintubation after impairment. Moreover, our means of classification of
CABG in patients with renal dysfunction. It is possible renal failure did not clearly distinguish between patients
that impaired renal function limits elimination of fluid with potentially reversible, hemodynamically mediated
volume, thereby predisposing patients to impaired alveo- renal dysfunction and those with chronic, intrinsic renal
lar gas exchange. Alternatively, the presence of renal disease. In this regard, consistent information on the
failure could result in decreased metabolism and/or elim- presence and degree of proteinuria and on blood urea
ination of sedative/hypnotic and analgesic medications, nitrogen concentration was not available from our data
thereby impairing ventilatory drive. One caveat is in bank. The lack of this information potentially limits our
order, however, in interpreting our ventilatory complica- ability to assess more accurately the contribution of a
tion data. During the conduct of the study, new protocols serum creatinine of more than 1.5 mg/dl to adverse post-
to attempt to reduce length of stay were introduced that CABG outcome. Finally, data on the rate of acceptance
could have impacted some of the ventilation outcomes of “high risk” patients from each of the 14 centers in-
we studied. Clearly, further studies to clarify and to delin- cluded in our analysis are not available. However, the
14 study centers were selected to be representative ofeate the mechanism(s) accounting for the association of
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10. Turner JS, Morgan CJ, Thakrar B, Pepper JR: Difficulties inall 43 VA cardiac surgery programs based on risk-
predicting outcome in cardiac surgery patients. Crit Care Med
adjusted 30 day mortality [31]. Moreover, we performed 23:1843–1850, 1995
an analysis to see if a differential risk-adjusted mortality 11. Mangano CM, Diamondestone LS, Ramsay JG, Aggarwal A,
Herskovitz A, Mangano DT: Renal dysfunction after myocardialrate for CABG-only procedures existed across these 14
revascularization: Risk factors, adverse outcomes and hospital re-participating hospitals. With exception of one facility, source utilization. Ann Intern Med 128:174–203, 1998
there was not a significant difference in observed-to- 12. Shroyer AL, Grover FL, Edwards FH: 1995 Coronary artery
bypass risk model: The society of thoracic surgeons adult cardiacexpected mortality ratios using 95% confidence intervals.
national data base. Ann Thorac Surg 65:879–884, 1998In summary, this study found that a serum creatinine 13. Owen CH, Summings RG, Sell TL, Schwab SJ, Jones RH: Coro-
concentration of more than 1.5 mg/dl is associated with nary artery bypass grafting in patients with dialysis-dependent re-
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disease undergoing cardiac surgery. Scand J Thorac CardiovascThe mechanisms involved in these adverse outcomes
Surg 29:187–193, 1995
require further study. Our identification that an elevated 16. Knochel JP: Biochemical alterations in advanced uremic failure,
in The Principles and Practice of Nephrology, edited by Jacobsonserum creatinine is associated with adverse CABG out-
HR, Striker GE, Klahr S, Philadelphia, B.C. Decker, 1991, ppcome may have some clinical application. For example,
682–684enhanced clinical evaluation and surveillance of this pop- 17. Shroyer AL, London MJ, VillaNueva C, Sethi GK, Marshall
ulation and perhaps specific prophylactic maneuvers G, Moritz TE, Henderson WG, McCarthy MJ, Grover FJ, Ham-
mermeister KE: The processes, structures and outcomes of carecould potentially improve outcome. Prospective inter-
in cardiac surgery study protocol. Med Care 33(Suppl):0S17–0S25,ventional studies will be required to test this hypothesis. 1995
18. Marshall G, Shroyer AL, Grover FL, Hammermeister KE:
Bayesian-logit model for risk assessment in coronary artery bypassACKNOWLEDGMENTS
grafting. Ann Thorac Surg 57:1440–1450, 1994
This work was supported by the Department of Veterans Affairs 19. Hosmer DW, Lemeshow S: Applied Logistic Regression. New
Health Services Research and Development Service and the Coopera- York, John Wiley and Sons, 1989, pp 82–132
tive Studies Program. Ms. Mary Miller provided secretarial assistance. 20. Ash A, Schwartz M: Evaluating the performance of risk-adjust-
ment methods: Dichotomous variables, in Risk Adjustment for
Reprint requests to Robert J. Anderson, M.D., Division of Internal Measuring Health Care Outcomes, edited by Iezzoni L, Ann Arbor,
Medicine, Box B-180, University of Colorado Health Sciences Center, Health Administration Press, 1994, pp 313–346
4200 East Ninth Avenue, Denver, Colorado 80262, USA. 21. Palda VA, Detsky AS: Perioperative assessment and manage-
E-mail: Robert.Anderson@UCHSC.edu ment of risk from coronary artery disease. Ann Intern Med 127:313–
328, 1997
22. Eagle KA, Brumdage BH, Chaitman BR, Ervey GA, FlesherREFERENCES
LA, Hertzer NR: Guidelines for perioperative cardiovascular
evaluation for noncardiac surgery. J Am Coll Cardiol 27:910–948,1. Grover FL, Hammermeister KE, Burchfiel C: Initial report of
1996the Veterans Administration preoperative risk assessment study
23. Mangano DT, Goldman L: Preoperative assessment of patientsfor cardiac surgery. Ann Thorac Surg 50:12–28, 1990
with known or suspected coronary disease. N Engl J Med 333:1750–2. Higgins TL, Estafanous FG, Loop FD, Beck GJ, Blum JM, Pa-
1756, 1995randi L: Stratification of morbidity and mortality outcome by
24. Daley J: Criteria by which to evaluate risk-adjusted outcome pro-preoperative risk factors in coronary artery bypass patients. JAMA
grams in cardiac surgery. Ann Thorac Surg 58:1827–1835, 1994267:2344–2348, 1992
25. Rigdon EE, Monajjem N, Rodes RS: Is carotid endarterectomy3. Browner WS, Li J, Mangano DT: In-hospital and long-term mor-
justified in patients with severe chronic renal insufficiency? Anntality in male veterans following noncardiac surgery. JAMA
Vasc Surg 11:115–119, 1997268:228–232, 1992
4. Hammermeister KE, Johnson R, Marshall G, Grover FL: Con- 26. Denton TA, Luevanos J, Matloff JM: Clinical and nonclinical
tinuous assessment and improvement in quality of care: A model predictors of the cost of coronary artery bypass surgery. Arch
from the Department of Veterans Affairs cardiac surgery. Ann Intern Med 158:886–871, 1998
Surg 219:382–390, 1994 27. Remuzzi G: Bleeding disorders in uremia: Pathophysiology and
5. O’Connor GT, Plume SK, Olmstead EM, Coffin LH, Martin treatment. Adv Nephrol 18:171–186, 1989
JR: Multivariate prediction of in-hospital mortality associated with 28. Livio M, Mannucci PM, Vigano G: Conjugated estrogens for the
coronary artery bypass graft surgery. Circulation 85:2110–2118, management of bleeding associated with renal failure. N Engl J
1992 Med 315:731–735, 1986
6. Clark RE: The society of thoracic surgeons national data base 29. Khuri SF, Wolfe JA, Josa M: Hematological changes during and
status report. Ann Thorac Surg 57:20–26, 1994 after cardiopulmonary bypass and their relationship to the bleeding
7. Hannan EL, Kilburn H, Rocz M, Sheilds E, Chassin MR: Im- time and nonsurgical blood loss. J Thorac Cardiovasc Surg 104:94–
proving the outcomes of coronary artery bypass surgery in New 107, 1992
York state. JAMA 271:761–766, 1994 30. Levy EM, Visioli CM, Horwitz RI: The effect of acute renal
8. Parsonnet V, Dean D, Bernstein AD: A method of uniform failure on mortality: A cohort analysis. JAMA 275:1487–1494, 1996
stratification of risk for evaluating the results of surgery in acquired 31. Henderson WG, Moritz TE, Shroyer AL, Johnson R, Marshall
adult heart disease. Circulation 79(Suppl I):3–12, 1989 G, Ellis NK, Sethi G, Grover FL, Hammermeister KE: An analy-
9. Tu JV, Mazer CD, Levington C, Armstrong PW, Naylor CD: sis of interobserver reliability and representativeness of data from
A predictive index for length of stay in the intensive care unit the Veterans Affairs Cooperative Study on processes, structures
following cardiac surgery. Can Med Assoc J 151:177–185, 1994 and outcomes in cardiac surgery. Med Care 33:0S86–0S101, 1995
